Related Experiment Video
Updated: Jul 11, 2026

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells
Published on: July 29, 2010
LIF- and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation
Norihiko Ohbayashi1, Osamu Ikeda, Naohisa Taira
1Department of Immunology, Graduate School of Pharmaceutical Sciences Hokkaido University, Kita-ku, Sapporo, Japan.
Abstract:
Signal transducer and activator of transcription 3 (STAT3), which mediates biological actions in many physiological processes, is activated by cytokines and growth factors via specific tyrosine or serine phosphorylation, dimerization and nuclear translocation. A recent study has demonstrated, by using antibody to acetylated lysine, and a STAT3 mutant with Lys-685-to-Arg substitution, that STAT3 is acetylated at Lys-685 by histone acetyltransferase p300, and that acetylation at Lys-685 is critical for STAT3 activation. In the present study, we created an acetyl-specific antibody against STAT3 acetylated at Lys-685, and found that leukemia inhibitory factor (LIF) or interleukin (IL)-6 induced acetylation of STAT3 at Lys-685 in 293T and Hep3B cells. Moreover, acetylation of STAT3 at Lys-685 was suppressed by PI3K inhibitor LY294002, or a dominant negative Akt. Taken together, our findings demonstrate that endogenous STAT3 is acetylated at Lys-685 by LIF or IL-6 through PI3K/Akt activation.
Insights
Leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) activate signal transducer and activator of transcription 3 (STAT3) through acetylation at Lys-685, mediated by the PI3K/Akt pathway.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Signal transducer and activator of transcription 3 (STAT3) regulates numerous physiological processes.
- STAT3 activation involves phosphorylation, dimerization, and nuclear translocation.
- Previous research identified Lys-685 acetylation by p300 as critical for STAT3 activation.
Purpose of the Study:
- To investigate the role of STAT3 acetylation at Lys-685 in response to specific cytokines.
- To elucidate the signaling pathway involved in STAT3 Lys-685 acetylation.
Main Methods:
- Development of an antibody specific to acetylated STAT3 at Lys-685.
- Treatment of 293T and Hep3B cells with leukemia inhibitory factor (LIF) or interleukin-6 (IL-6).
- Inhibition of the PI3K/Akt pathway using LY294002 or a dominant-negative Akt mutant.
Main Results:
- LIF and IL-6 induced STAT3 acetylation at Lys-685 in treated cells.
- STAT3 Lys-685 acetylation was significantly reduced by PI3K/Akt pathway inhibitors.
- Endogenous STAT3 acetylation at Lys-685 is confirmed to be regulated by LIF/IL-6 via PI3K/Akt.
Conclusions:
- STAT3 acetylation at Lys-685 is a key regulatory event induced by LIF and IL-6.
- The PI3K/Akt signaling pathway is essential for mediating STAT3 Lys-685 acetylation.
- This study provides novel insights into the post-translational modification and activation of STAT3.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade

